Development of Chromosome 1q+ Specific Treatment for Highest Risk Pediatric Posterior Fossa Ependymoma.

Overview of attention for article published in Clinical Cancer Research, February 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (57th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 12,077 followers.

RT @EANOassociation: Development of chromosome 1q+ specific treatment for highest risk pediatric posterior fossa #ependymoma. https://t.co/…

RT @EANOassociation: Development of chromosome 1q+ specific treatment for highest risk pediatric posterior fossa #ependymoma. https://t.co/…

RT @EANOassociation: Development of chromosome 1q+ specific treatment for highest risk pediatric posterior fossa #ependymoma. https://t.co/…

Development of chromosome 1q+ specific treatment for highest risk pediatric posterior fossa #ependymoma. https://t.co/tx5mClnGb2 #btsm @CCR_AACR

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.